ALK-positive primary systemic anaplastic large cell lymphoma with extensive cutaneous manifestation.
Ando
Kazuha
K
Tamada
Yasuhiko
Y
Shimizu
Kazuyuki
K
Akita
Yoichi
Y
Watanabe
Daisuke
D
Nakamura
Shigeru
S
Hara
Kazuo
K
Matsumoto
Yoshinari
Y
D000293:Adolescent; D000328:Adult; D000077548:Anaplastic Lymphoma Kinase; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001706:Biopsy; D005260:Female; D006801:Humans; D017728:Lymphoma, Large-Cell, Anaplastic / Q000188:drug therapy / Q000201:enzymology* / Q000473:pathology; D010778:Photochemotherapy; D011505:Protein-Tyrosine Kinases / Q000032:analysis*; D020794:Receptor Protein-Tyrosine Kinases; D012008:Recurrence; D012867:Skin / Q000473:pathology; D012878:Skin Neoplasms / Q000188:drug therapy / Q000201:enzymology* / Q000473:pathology; D013997:Time Factors; D016896:Treatment Outcome; D055815:Young Adult
C000626173:ALK protein, human; D000077548:Anaplastic Lymphoma Kinase; D011505:Protein-Tyrosine Kinases; D020794:Receptor Protein-Tyrosine Kinases